{
  "@context": "aku-v2",
  "@type": "definition",
  "@id": "wsmg:health-sciences/medicine/cardiology/cardio-048",
  "metadata": {
    "version": "4.0.0",
    "created": "2026-01-09T01:50:10.000Z",
    "modified": "2026-01-13T15:03:00.000Z",
    "contributors": [
      "copilot-agent",
      "quality-enhancement-agent",
      "quality-agent"
    ],
    "confidence": 0.96,
    "status": "validated",
    "language": "en",
    "licenses": ["CC-BY-4.0"]
  },
  "classification": {
    "domain_path": "health-sciences/medicine/cardiology",
    "subdomain": "diagnostic_testing",
    "type": "definition",
    "difficulty": "intermediate",
    "importance": "high",
    "isNativeDomain": true,
    "board_yield": "HIGH"
  },
  "content": {
    "title": "Cardiac Biomarkers",
    "summary": "Cardiac biomarkers are blood-based molecules used to diagnose, risk-stratify, and monitor cardiac diseases. High-sensitivity troponin (hs-cTn) is the gold standard for myocardial infarction diagnosis. BNP and NT-proBNP are used for heart failure diagnosis and prognosis. Understanding kinetics and non-cardiac causes of elevation is essential for interpretation.",
    "key_points": [
      "High-sensitivity troponin I or T: gold standard for MI diagnosis",
      "Troponin elevation requires rise/fall pattern + clinical context for MI diagnosis",
      "BNP/NT-proBNP: heart failure diagnosis, prognostication, and treatment monitoring",
      "BNP <100 or NT-proBNP <300 pg/mL makes acute HF unlikely (high NPV)",
      "Many non-cardiac causes of troponin elevation exist (renal failure, sepsis, PE)",
      "CK-MB largely replaced by troponin; may help detect reinfarction timing"
    ],
    "statement": "Cardiac biomarkers including high-sensitivity troponin for myocardial injury and natriuretic peptides for heart failure are essential diagnostic and prognostic tools, requiring understanding of kinetics, cutoffs, and non-cardiac causes of elevation.",
    "explanation": {
      "intuition": "When heart muscle is damaged, it releases proteins into the bloodstream like a cracked container leaking its contents. Troponin leaks from injured heart cells; natriuretic peptides are released when the heart is stretched from volume/pressure overload. These blood tests are like 'smoke detectors' for cardiac problems.",
      "key_insight": "Troponin elevation alone does not equal MI - it indicates myocardial injury. The 4th Universal Definition of MI requires clinical evidence of ischemia PLUS rise/fall pattern. Chronic troponin elevation (stable levels) suggests chronic injury (heart failure, renal failure) rather than acute MI.",
      "technical_details": "High-sensitivity troponin assays detect levels 10-100x lower than conventional assays, enabling earlier MI detection. The 99th percentile URL is the diagnostic threshold. Natriuretic peptides are cleaved from proBNP: BNP is the active hormone (cleared by NPR-C and neprilysin); NT-proBNP is inactive and renally cleared."
    },
    "definitions_glossary": {
      "troponin": "Cardiac structural protein released during myocyte injury; I and T subtypes",
      "high_sensitivity_troponin": "hs-cTn; assay detecting very low troponin concentrations",
      "99th_percentile_URL": "Upper reference limit defining elevated troponin",
      "rise_and_fall_pattern": "Dynamic troponin change indicating acute myocardial injury",
      "BNP": "Brain natriuretic peptide; released from ventricular myocytes with stretch",
      "NT_proBNP": "Inactive N-terminal fragment of proBNP; renally cleared",
      "myocardial_injury": "Elevated troponin from any cause (ischemic or non-ischemic)",
      "myocardial_infarction": "Myocardial injury + ischemic etiology (clinical evidence)",
      "type_1_MI": "MI from atherothrombotic plaque rupture",
      "type_2_MI": "MI from supply-demand mismatch (tachycardia, hypotension, anemia)",
      "CK_MB": "Creatine kinase MB isoenzyme; less specific than troponin",
      "acute_coronary_syndrome": "Spectrum including STEMI, NSTEMI, unstable angina"
    }
  },
  "clinical_features": {
    "pathophysiology": {
      "troponin": {
        "source": "Cardiac myocyte contractile apparatus (troponin complex)",
        "release_mechanism": "Myocyte necrosis, membrane damage, or active release",
        "kinetics": {
          "onset": "Detectable 1-3 hours after injury with hs-cTn",
          "peak": "12-24 hours",
          "duration": "Elevated for 5-14 days depending on infarct size"
        }
      },
      "natriuretic_peptides": {
        "source": "Ventricular myocardium (primarily); some atrial contribution",
        "stimulus": "Wall stretch from volume or pressure overload",
        "effects": ["Natriuresis", "Vasodilation", "RAAS suppression"],
        "half_life": "BNP ~20 min; NT-proBNP ~90-120 min"
      }
    },
    "diagnostic_criteria": {
      "troponin_interpretation": {
        "MI_diagnosis_4th_UDMI": {
          "criteria": [
            "Detection of rise and/or fall of cTn with at least one value above 99th percentile URL",
            "Plus clinical evidence of myocardial ischemia (symptoms, ECG changes, imaging evidence, or angiographic evidence)"
          ]
        },
        "serial_testing": {
          "0_1h_algorithm": "Baseline + 1h troponin; rule-out if both low without significant change",
          "0_3h_algorithm": "Baseline + 3h troponin",
          "delta_criteria": "Change >20% over 3-6h suggests acute injury"
        },
        "non_ACS_causes": [
          "Heart failure",
          "Myocarditis",
          "Pulmonary embolism",
          "Renal failure (chronically elevated)",
          "Sepsis",
          "Tachy/brady arrhythmias",
          "Hypertensive crisis",
          "Takotsubo cardiomyopathy",
          "Cardiac procedures (TAVR, ablation)"
        ]
      },
      "natriuretic_peptides": {
        "acute_HF_diagnosis": {
          "BNP": "<100 pg/mL: HF unlikely; >400 pg/mL: HF likely",
          "NT_proBNP": "<300 pg/mL: HF unlikely; >900 pg/mL (age 50-75) or >1800 (>75): HF likely",
          "gray_zone": "Intermediate values require clinical judgment"
        },
        "chronic_HF_prognosis": "Higher levels = worse prognosis",
        "elevated_non_HF": ["Renal failure", "Atrial fibrillation", "Pulmonary hypertension", "Sepsis", "Age (higher in elderly)"]
      }
    },
    "differential_diagnosis": [
      "Type 1 vs Type 2 MI",
      "Acute vs chronic myocardial injury",
      "Cardiac vs non-cardiac cause of troponin elevation",
      "Heart failure vs other dyspnea causes (using BNP/NT-proBNP)"
    ],
    "treatment_options": {
      "interpretation_guides_therapy": {
        "elevated_troponin_with_ischemia": "Treat as ACS per guidelines",
        "elevated_troponin_without_ischemia": "Identify and treat underlying cause (type 2 MI, myocarditis, etc.)",
        "chronic_stable_elevation": "Reflects underlying cardiac disease; not indication for ACS therapy"
      },
      "BNP_guided_therapy": {
        "evidence": "GUIDE-IT trial did not show benefit of BNP-guided therapy over usual care",
        "current_use": "Diagnosis, prognosis, and assessing response to therapy"
      }
    }
  },
  "skos": {
    "prefLabel": {
      "@language": "en",
      "@value": "Cardiac Biomarkers"
    },
    "altLabel": [
      {"@language": "en", "@value": "Cardiac enzymes"},
      {"@language": "en", "@value": "Troponin"},
      {"@language": "en", "@value": "BNP and NT-proBNP"}
    ],
    "definition": {
      "@language": "en",
      "@value": "Blood-based molecules including troponin and natriuretic peptides used to diagnose, risk-stratify, and monitor cardiac diseases"
    },
    "notation": "cardio-048",
    "scopeNote": {
      "@language": "en",
      "@value": "Covers troponin for MI diagnosis, natriuretic peptides for heart failure, kinetics, and interpretation pitfalls"
    }
  },
  "relationships": {
    "skos:broader": [
      {
        "@id": "wsmg:health-sciences/medicine/cardiology/diagnostic-testing",
        "skos:prefLabel": "Cardiac Diagnostic Testing"
      }
    ],
    "skos:related": [
      {
        "@id": "wsmg:health-sciences/medicine/cardiology/cardio-002",
        "skos:prefLabel": "Acute Coronary Syndrome"
      },
      {
        "@id": "wsmg:health-sciences/medicine/cardiology/cardio-004",
        "skos:prefLabel": "Heart Failure"
      }
    ],
    "owl:sameAs": [
      "http://dbpedia.org/resource/Troponin"
    ]
  },
  "medicalCode": [
    {
      "@type": "MedicalCode",
      "codingSystem": "SNOMED-CT",
      "codeValue": "105000003",
      "uri": "http://snomed.info/id/105000003",
      "description": "Troponin level"
    },
    {
      "@type": "MedicalCode",
      "codingSystem": "LOINC",
      "codeValue": "10839-9",
      "uri": "http://loinc.org/10839-9",
      "description": "Troponin I cardiac"
    },
    {
      "@type": "MedicalCode",
      "codingSystem": "MeSH",
      "codeValue": "D014336",
      "uri": "http://id.nlm.nih.gov/mesh/D014336",
      "description": "Troponin"
    }
  ],
  "pedagogical": {
    "learning_objectives": [
      "Apply the 4th Universal Definition of MI using troponin criteria",
      "Interpret troponin values using rise/fall pattern and clinical context",
      "Use BNP/NT-proBNP to diagnose and risk-stratify heart failure",
      "Identify non-cardiac causes of troponin elevation",
      "Distinguish Type 1 from Type 2 MI based on mechanism"
    ],
    "clinical_pearls": [
      "Elevated troponin â‰  MI; requires rise/fall PLUS clinical evidence of ischemia",
      "Stable chronically elevated troponin (renal failure, HF) does not indicate acute MI",
      "BNP <100 or NT-proBNP <300 has >95% NPV for ruling out acute HF",
      "Obesity falsely lowers BNP; renal failure falsely elevates NT-proBNP",
      "hs-cTn detects earlier but also detects more non-ACS causes of elevation"
    ],
    "board_yield": "HIGH",
    "estimated_time": "20min",
    "target_audience": [
      "medical_students",
      "internal_medicine_residents",
      "emergency_medicine_physicians",
      "cardiology_fellows"
    ],
    "common_misconceptions": [
      "Any troponin elevation is a heart attack - type 2 MI and non-ischemic injury are common",
      "Normal troponin at presentation rules out MI - serial testing needed",
      "CK-MB is still first-line - troponin has replaced it as gold standard"
    ]
  },
  "prerequisites": [
    {
      "@id": "wsmg:health-sciences/medicine/cardiology/acs-overview",
      "skos:prefLabel": "Acute Coronary Syndrome Overview"
    }
  ],
  "related_concepts": [
    "myocardial infarction",
    "heart failure",
    "chest pain evaluation",
    "risk stratification"
  ],
  "evidence": {
    "citations": [
      {
        "authors": "Thygesen K, Alpert JS, Jaffe AS, et al.",
        "title": "Fourth Universal Definition of Myocardial Infarction",
        "journal": "Circulation",
        "year": 2018,
        "volume": "138",
        "pages": "e618-e651",
        "doi": "10.1161/CIR.0000000000000617"
      }
    ],
    "confidence_rationale": "Based on 4th Universal Definition of MI and biomarker guidelines"
  },
  "provenance": {
    "verification_status": "verified",
    "last_verified": "2026-01-13T15:03:00.000Z",
    "sources": [
      {
        "source": "Harrison's Principles of Internal Medicine, 21st ed.",
        "type": "textbook",
        "year": 2022,
        "isbn": "978-1264268504",
        "relevance": "Standard internal medicine reference"
      },
      {
        "source": "4th Universal Definition of MI",
        "type": "clinical_guideline",
        "year": 2018,
        "relevance": "Definitive MI diagnostic criteria"
      }
    ]
  },
  "quality_assessment": {
    "content_quality_score": 0.95,
    "completeness": 0.96,
    "accuracy": 0.97,
    "clarity": 0.94,
    "clinical_relevance": 0.97,
    "last_assessed": "2026-01-13T15:03:00.000Z"
  },
  "owl:sameAs": "http://dbpedia.org/resource/Troponin",
  "skos:exactMatch": "http://www.wikidata.org/entity/Q336388"
}